文献速递胃肠外科围术期管理与 ERAS

袖状胃切除与高血压:长期结局的系统综述

Sleeve gastrectomy and hypertension: a systematic review of long-term outcomes.
PubMed 文献 · Surg Endosc · 2018-11-01

该系统综述纳入14项研究、共3550例接受腹腔镜袖状胃切除术(LSG)的肥胖患者,评估术后至少5年的高血压结局。术前高血压患病率为36.5%,约5年随访时降至14.79%;高血压缓解率为62.17%,改善率为35.7%,平均随访5.35年。结论认为LSG对合并高血压的减重患者有效。

要点

  • LSG术后约5年高血压患病率由36.5%降至14.79%。
  • 高血压缓解率62.17%,改善率35.7%,平均随访5.35年。
  • LSG或可减少降压药使用并带来成本节约,尚需前瞻性研究。

核心结论

  • 该系统综述认为,腹腔镜袖状胃切除术是治疗合并高血压的减重患者的有效干预措施。
  • 除高血压发生率下降外,LSG可能带来减少降压药物使用等额外卫生系统收益。
  • 建议进一步开展前瞻性研究,评估减少长期降压药物使用所带来的成本节约。

研究设计与样本

  • 系统综述,检索Medline、Embase、Scopus、Web of Science、DARE、Cochrane library及HTA数据库。
  • 纳入接受LSG、随访高血压结局至少5年的成年患者,排除修正手术,由两名独立评价者参与。
  • 共纳入14项研究,合计3550例受试者。

主要发现

  • 受试者平均年龄41.1 ± 10.7岁,术前平均BMI为47.7 ± 8.83 kg/m2、平均体重272.8 ± 48.4 lb。
  • 术前高血压患病率为36.5%(范围6.7-91%),约5年随访时降至14.79%(范围0-33.3%)。
  • 平均随访5.35年时,高血压缓解率为62.17%(范围0-100%),改善率为35.7%(范围13.3-76.9%)。

关键数值与推荐

  • 纳入标准:接受LSG且随访高血压结局至少5年的成年患者,排除修正手术。
  • 结局指标:高血压患病率、缓解率与改善率,随访时间至少5年。

临床怎么用

  • 对合并高血压的肥胖患者,LSG可作为兼顾减重与改善高血压的长期干预选择。
  • 术后应长期随访血压及降压药物使用情况,评估缓解与改善状态。

局限性

  • 高血压缓解率与改善率的研究间范围较宽(缓解0-100%、改善13.3-76.9%),异质性明显。
  • 纳入研究均为观察性数据汇总,缺乏前瞻性成本节约评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Bariatric surgery has been shown to be a safe and durable intervention for patients struggling with obesity and metabolic syndrome, including hypertension. Buchwald et al. reported hypertension resolution rates in 67.1% and improvement in 78.5% following aggregate bariatric surgery. The laparoscopic sleeve gastrectomy (LSG) is becoming increasingly utilized as a primary bariatric surgery, but lacks long-term outcome data. There are a growing number of studies reporting outcome data beyond 5 years. OBJECTIVE: This study aims to systematically evaluate the efficacy of laparoscopic sleeve gastrectomy on hypertension amongst obese patients. MATERIALS AND METHODS: A comprehensive literature search was conducted through Medline, Embase, Scopus, Web of Science, Dare, Cochrane library, and HTA database. The search terms used were broad: sleeve gastrectomy AND hypertension OR blood pressure. Adult patients undergoing LSG with follow-up hypertension outcome results of at least 5 years were included. Revisional surgeries were excluded. Two independent reviewers were used. RESULTS: Fourteen studies were included in this systematic review, which included 3550 subjects in total. Mean age was 41.1 ± 10.7 years. Mean pre-operative BMI and weight were 47.7 ± 8.83 kg/m2 and 272.8 ± 48.4 lb, respectively. Pre-operative prevalence of hypertension was 36.5% (range 6.7-91%) which dropped to 14.79% (range 0-33.3%) at approximately 5-year follow-up. Hypertension resolved in 62.17% (range 0-100%) of patients and improved in 35.7% (range 13.3-76.9%) at a mean of 5.35 years of follow-up. CONCLUSION: From this systematic review, LSG is an effective intervention for bariatric patients with hypertension. In addition to the observed reduction in the incidence of hypertension, it is likely that LSG may lead to additional health system benefits such as cost savings due to reductions in antihypertensive medications. Further prospective studies should include estimates of cost savings associated with reductions in chronic antihypertensive medication usage.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Graham C, Switzer N, Reso A, et al. Sleeve gastrectomy and hypertension: a systematic review of long-term outcomes. Surg Endosc. 2018. PMID: 30386988. doi:10.1007/s00464-018-6566-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。